Mineralys Therapeutics (MLYS) Institutional Ownership $29.88 +1.03 (+3.55%) As of 10:09 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Mineralys Therapeutics (NASDAQ:MLYS)CurrentInstitutional OwnershipPercentage84.46%Number ofInstitutional Buyers(last 12 months)97TotalInstitutional Inflows(last 12 months)$242.46MNumber ofInstitutional Sellers(last 12 months)26TotalInstitutional Outflows(last 12 months)$49.50M Get MLYS Insider Trade Alerts Want to know when executives and insiders are buying or selling Mineralys Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data MLYS Institutional Buying and Selling by Quarter Mineralys Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/28/2025 China Universal Asset Management Co. Ltd.13,090$177K0.0%+31.0%0.020% 8/15/2025 Rafferty Asset Management LLC57,375$776K0.0%N/A0.087% 8/15/2025 Man Group plc21,852$296K0.0%+50.1%0.033% 8/15/2025 BNP Paribas Financial Markets4,108$56K0.0%-93.3%0.006% 8/15/2025 Boothbay Fund Management LLC816,926$11.05M0.2%-12.5%1.232% 8/15/2025 Bellevue Group AG15,556$210K0.0%-5.7%0.023% 8/15/2025 Balyasny Asset Management L.P.205,723$2.78M0.0%+37.8%0.310% 8/15/2025 Bank of America Corp DE263,356$3.56M0.0%+78.9%0.397% 8/15/2025 Ameriprise Financial Inc.50,857$688K0.0%N/A0.077% 8/14/2025 Nantahala Capital Management LLC353,982$4.79M0.2%-55.1%0.543% Get the Latest News and Ratings for MLYS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Mineralys Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/14/2025 Orbimed Advisors LLC760,351$10.29M0.3%N/A1.167% 8/14/2025 California State Teachers Retirement System36,592$495K0.0%+1,668.6%0.056% 8/14/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.24,237$328K0.0%+41.9%0.037% 8/14/2025 Armistice Capital LLC178,000$2.41M0.0%N/A0.273% 8/14/2025 The Manufacturers Life Insurance Company 14,775$200K0.0%+29.8%0.023% 8/14/2025 OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC 79,723$1.08M0.1%+8.7%0.122% 8/14/2025 HighVista Strategies LLC150,138$2.03M0.7%N/A0.230% 8/14/2025 Stempoint Capital LP631,586$8.55M2.7%-605.3%0.969% 8/14/2025 Velan Capital Investment Management LP174,600$2.36M2.3%+15.9%0.268% 8/14/2025 Qube Research & Technologies Ltd351,113$4.75M0.0%N/A0.539% 8/14/2025 22NW LP560,042$7.58M5.5%+21.4%0.859% 8/14/2025 Pale Fire Capital SE446,626$6.04M0.6%+11.8%0.685% 8/14/2025 Federated Hermes Inc.16,528$224K0.0%+38.3%0.025% 8/13/2025 Walleye Capital LLC73,921$1M0.0%N/A0.113% 8/13/2025 Invesco Ltd.25,743$348K0.0%-91.7%0.039% 8/13/2025 Virtus Investment Advisers LLC6,302$85K0.0%-53.3%0.010% 8/13/2025 Quadrature Capital Ltd11,987$162K0.0%-83.6%0.018% 8/12/2025 Ameritas Investment Partners Inc.3,995$54K0.0%+42.8%0.006% 8/12/2025 Prudential Financial Inc.352,225$4.77M0.0%+176.5%0.540% 8/12/2025 American Century Companies Inc.834,781$11.30M0.0%+1.4%1.281% 8/12/2025 Rhumbline Advisers53,596$725K0.0%+36.2%0.082% 8/12/2025 Franklin Resources Inc.1,803,597$24.40M0.0%+1.3%2.767% 8/12/2025 Legal & General Group Plc36,049$488K0.0%+1,296.2%0.055% 8/12/2025 JPMorgan Chase & Co.25,500$345K0.0%-219.5%0.039% 8/12/2025 Swiss National Bank61,900$838K0.0%N/A0.095% 8/12/2025 Ensign Peak Advisors Inc107,640$1.46M0.0%+187.1%0.165% 8/11/2025 Greenland Capital Management LP10,000$135K0.0%-50.0%0.015% 8/8/2025 Intech Investment Management LLC21,629$293K0.0%N/A0.033% 8/8/2025 Creative Planning24,861$336K0.0%N/A0.038% 8/8/2025 SG Americas Securities LLC123,987$1.68M0.0%+1,085.7%0.190% Turn $1K into $50K with This DeFi Gem (Ad)Bitcoin grabs headlines, but smart money likes this token My research team has identified the token positioned at the absolute center of this incoming capital flood— a project so fundamentally essential to the crypto ecosystem that institutional investors simply cannot ignore it.Click here to get all the details8/8/2025 Candriam S.C.A.824,187$11.15M0.1%-6.6%1.264% 8/8/2025 Police & Firemen s Retirement System of New Jersey9,234$125K0.0%+29.4%0.014% 8/8/2025 Geode Capital Management LLC954,560$12.92M0.0%+19.0%1.464% 8/7/2025 ProShare Advisors LLC10,457$141K0.0%N/A0.016% 8/7/2025 Profund Advisors LLC12,131$164K0.0%N/A0.019% 8/6/2025 Fox Run Management L.L.C.16,243$220K0.0%N/A0.025% 8/1/2025 Jennison Associates LLC1,235,322$16.71M0.0%-37.6%1.895% 8/1/2025 Y Intercept Hong Kong Ltd21,280$288K0.0%N/A0.033% 7/31/2025 AlphaQuest LLC14,841$201K0.0%-6.8%0.023% 7/28/2025 Allianz Asset Management GmbH12,300$166K0.0%N/A0.019% 7/25/2025 CWM LLC6,251$85K0.0%-25.1%0.010% 7/23/2025 KLP Kapitalforvaltning AS6,700$91K0.0%N/A0.010% 7/21/2025 Mirae Asset Global Investments Co. Ltd.2,518$34K0.0%+51.0%0.004% 7/10/2025 Swedbank AB383,800$5.19M0.0%+17.1%0.589% 6/27/2025 Goldman Sachs Group Inc.298,395$4.74M0.0%+166.6%0.458% 6/23/2025 Swedbank AB327,700$5.20M0.0%N/A0.503% 6/18/2025 Voya Investment Management LLC16,058$255K0.0%N/A0.025% 5/29/2025 Rhumbline Advisers39,361$625K0.0%-2.9%0.060% 5/28/2025 Strs Ohio22,600$359K0.0%N/A0.035% 5/16/2025 Woodline Partners LP47,662$757K0.0%N/A0.073% 5/16/2025 Goldman Sachs Group Inc.298,395$4.74M0.0%+166.6%0.460% 5/16/2025 Parkman Healthcare Partners LLC293,928$4.67M0.6%N/A0.453% 5/16/2025 Polar Asset Management Partners Inc.20,130$320K0.0%-79.7%0.031% 5/16/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.17,085$271K0.0%+4.3%0.026% 5/16/2025 Cinctive Capital Management LP14,219$226K0.0%N/A0.022% 5/16/2025 AQR Capital Management LLC34,615$550K0.0%N/A0.053% 5/16/2025 ADAR1 Capital Management LLC263,425$4.18M0.8%-68.7%0.406% 5/15/2025 RA Capital Management L.P.6,147,280$97.62M1.6%+26.7%9.475% 5/15/2025 Nantahala Capital Management LLC787,740$12.51M0.5%+24.5%1.214% 5/15/2025 Quarry LP7,000$111K0.0%N/A0.011% 5/15/2025 DAFNA Capital Management LLC309,200$4.91M1.4%+111.1%0.477% 5/15/2025 Velan Capital Investment Management LP150,600$2.39M2.5%N/A0.232% 5/15/2025 Canada Pension Plan Investment Board279,500$4.44M0.0%N/A0.431% 5/15/2025 Trexquant Investment LP126,535$2.01M0.0%N/A0.195% 5/14/2025 22NW LP461,344$7.33M5.6%N/A0.711% 5/14/2025 Pale Fire Capital SE399,498$6.34M0.8%+191.8%0.616% 5/14/2025 AlphaQuest LLC15,925$253K0.0%+4.6%0.025% 5/14/2025 Monashee Investment Management LLC112,457$1.79M0.2%N/A0.173% 5/14/2025 Candriam S.C.A.882,833$14.02M0.1%+189.2%1.361% 5/14/2025 Erste Asset Management GmbH45,000$660K0.0%N/A0.069% 5/14/2025 Wellington Management Group LLP121,557$1.93M0.0%+32.8%0.187% 5/13/2025 SR One Capital Management LP3,127,933$49.67M12.8%+55.1%4.821% 5/13/2025 American Century Companies Inc.823,616$13.08M0.0%-2.9%1.270% 5/13/2025 Informed Momentum Co LLC164,273$2.61M0.5%N/A0.253% 5/12/2025 Nuveen LLC67,877$1.08M0.0%N/A0.105% 5/12/2025 Virtu Financial LLC25,203$400K0.0%N/A0.039% 5/12/2025 Invesco Ltd.308,310$4.90M0.0%N/A0.475% 5/9/2025 Deutsche Bank AG296,015$4.70M0.0%+1,007.3%0.456% 5/9/2025 Charles Schwab Investment Management Inc.270,175$4.29M0.0%+25.7%0.416% 5/9/2025 Vanguard Group Inc.2,035,506$32.32M0.0%+42.1%3.138% How “Trump’s New Dollar” Could Impact Your Wealth (Ad)President Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking and savings account… With this better, more technologically advanced dollar. President Trump himself called it a "big innovation"… And said that this new form of currency represents "American brilliance at its best."Click here now because Chase, Bank of America, Citigroup, Wells Fargo, and U.S. Bancorp…5/8/2025 XTX Topco Ltd13,785$219K0.0%N/A0.021% 5/8/2025 Federated Hermes Inc.11,951$190K0.0%-23.0%0.018% 5/5/2025 Jennison Associates LLC1,979,033$31.43M0.0%+82.9%3.050% 5/2/2025 SBI Securities Co. Ltd.1,590$25K0.0%+297.5%0.002% 5/1/2025 CWM LLC8,342$132K0.0%+59.3%0.013% 4/30/2025 Alps Advisors Inc.34,664$550K0.0%-13.9%0.053% 4/29/2025 Bank of New York Mellon Corp67,868$1.08M0.0%+3.9%0.105% 4/8/2025 Rhumbline Advisers39,361$625K0.0%-2.9%0.063% 4/7/2025 GAMMA Investing LLC8,829$140K0.0%+9,602.2%0.014% 3/24/2025 Wellington Management Group LLP91,529$1.13M0.0%+43.0%0.146% (Data available from 1/1/2016 forward) MLYS Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of MLYS shares? During the previous two years, 125 institutional investors and hedge funds held shares of Mineralys Therapeutics. The most heavily invested institutionals were RA Capital Management L.P. ($97.62M), Catalys Pacific LLC ($79.07M), SR One Capital Management LP ($49.67M), Vanguard Group Inc. ($32.32M), Franklin Resources Inc. ($24.40M), Braidwell LP ($19.25M), and Jennison Associates LLC ($16.71M).Learn more on Mineralys Therapeutics' institutional investors. What percentage of Mineralys Therapeutics' stock is owned by institutional investors? 84.46% of Mineralys Therapeutics' stock is owned by institutional investors. Learn more on MLYS's institutional investor holdings. Which institutional investors have been buying Mineralys Therapeutics' stock? Of the 113 institutional investors that purchased Mineralys Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Catalys Pacific LLC ($9.19M), RA Capital Management L.P. ($2.97M), Braidwell LP ($1.47M), SR One Capital Management LP ($1.33M), Jennison Associates LLC ($1.30M), Stempoint Capital LP ($1.16M), and Millennium Management LLC ($1.00M). How much institutional buying is happening at Mineralys Therapeutics? Institutional investors have bought a total of 16,927,512 shares in the last 24 months. This purchase volume represents approximately $242.46M in transactions. Which of Mineralys Therapeutics' major shareholders have been selling company stock? Of the 26 institutional investors that sold Mineralys Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Jennison Associates LLC ($743.71K), ADAR1 Capital Management LLC ($578.12K), Nantahala Capital Management LLC ($433.76K), Adams Street Partners LLC ($402.85K), Orbimed Advisors LLC ($391.30K), Invesco Ltd. ($282.57K), and Sphera Funds Management LTD. ($252.08K). How much institutional selling is happening at Mineralys Therapeutics? Institutional investors have sold a total of 3,646,600 shares in the last 24 months. This volume of shares sold represents approximately $49.50M in transactions. Related Companies AKRO Institutional Ownership ZLAB Institutional Ownership MIRM Institutional Ownership MLTX Institutional Ownership PTGX Institutional Ownership APLS Institutional Ownership MTSR Institutional Ownership SRRK Institutional Ownership KYMR Institutional Ownership AMRX Institutional Ownership This page (NASDAQ:MLYS) was last updated on 9/3/2025 by MarketBeat.com Staff From Our PartnersHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe $365M annual revenue crypto play While Bitcoin generates zero operational revenue, one DeFi protocol qu...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mineralys Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mineralys Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MLYS Stock Alerts